Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
PAVmed to host business news update conference call » 16:25
05/21/20
05/21
16:25
05/21/20
16:25
PAVM

PAVmed

$2.63 /

+0.01 (+0.38%)

Chairman & CEO Aklog…

Chairman & CEO Aklog and President & CFO McGrath holds a business news update conference call to be held on May 21 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
PAVM PAVmed
$2.63 /

+0.01 (+0.38%)

PAVM PAVmed
$2.63 /

+0.01 (+0.38%)

PAVM PAVmed
$2.63 /

+0.01 (+0.38%)

Conference/Events
PAVmed to host business news update conference call » 04:55
05/21/20
05/21
04:55
05/21/20
04:55
PAVM

PAVmed

$2.62 /

+0.13 (+5.22%)

Chairman & CEO Aklog…

Chairman & CEO Aklog and President & CFO McGrath holds a business news update conference call to be held on May 21 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
PAVM PAVmed
$2.62 /

+0.13 (+5.22%)

PAVM PAVmed
$2.62 /

+0.13 (+5.22%)

PAVM PAVmed
$2.62 /

+0.13 (+5.22%)

Conference/Events
PAVmed to host business news update conference call » 14:05
05/15/20
05/15
14:05
05/15/20
14:05
PAVM

PAVmed

$2.23 /

-0.02 (-0.89%)

Chairman & CEO Aklog…

Chairman & CEO Aklog and President & CFO McGrath holds a business news update conference call to be held on May 21 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
PAVM PAVmed
$2.23 /

-0.02 (-0.89%)

PAVM PAVmed
$2.23 /

-0.02 (-0.89%)

PAVM PAVmed
$2.23 /

-0.02 (-0.89%)

Over a month ago
Hot Stocks
PAVmed receives FDA 510(k) clearance for CarpX carpal tunnel device » 09:31
04/21/20
04/21
09:31
04/21/20
09:31
PAVM

PAVmed

$2.31 /

-0.125 (-5.14%)

PAVmed announced it has…

PAVmed announced it has received 510(k) marketing clearance from the U.S. FDA for its CarpX minimally invasive carpal tunnel device. The FDA determined that CarpX is "substantially equivalent to legally marketed predicates" and that PAVmed may market CarpX for "the minimally invasive isolation and incision/division of ligaments, tendons, or fascia such as the transverse carpal ligament for treatment of carpal tunnel syndrome." The FDA reached this determination after reviewing detailed data from the company's successful CarpX clinical safety study performed in New Zealand.

On The Fly
Fly Intel: After-Hours Movers » 19:09
04/09/20
04/09
19:09
04/09/20
19:09
PAVM

PAVmed

$1.91 /

+0.01 (+0.53%)

, BCRX

BioCryst

$2.05 /

+0.065 (+3.27%)

, HA

Hawaiian Holdings

$11.82 /

+0.57 (+5.07%)

, I

Intelsat

$1.56 /

-0.09 (-5.47%)

, WDFC

WD-40

$175.47 /

+1.13 (+0.65%)

, AERI

Aerie Pharmaceuticals

$15.24 /

+1.91 (+14.33%)

, BOOT

Boot Barn

$15.96 /

+0.18 (+1.14%)

Check out this…

Open Full Text

ShowHide Related Items >><<
PAVM PAVmed
$1.91 /

+0.01 (+0.53%)

BCRX BioCryst
$2.05 /

+0.065 (+3.27%)

03/05/20 Piper Sandler
BioCryst's berotralstat should still be approved this year, says Piper Sandler
02/18/20 JMP Securities
JMP says BioCryst should react favorably to NDA acceptance, lack of AdComm
11/15/19
Fly Intel: Top five analyst upgrades
11/15/19 BofA
BioCryst upgraded to Buy from Neutral at BofA/Merrill
HA Hawaiian Holdings
$11.82 /

+0.57 (+5.07%)

04/01/20 Stifel
Hawaiian Holdings upgraded to Hold from Sell at Stifel
03/25/20 Deutsche Bank
Deutsche Bank upgrades eight Airlines to Buy on stimulus agreement
03/25/20 Deutsche Bank
Hawaiian Holdings upgraded to Buy from Sell at Deutsche Bank
01/21/20 Buckingham
Airline industry to deliver Q4 pre-tax profits of $4.4B, says Buckingham
I Intelsat
$1.56 /

-0.09 (-5.47%)

04/01/20 Goldman Sachs
Intelsat downgraded to Sell from Neutral at Goldman Sachs
03/27/20 Cowen
Intelsat downgraded to Market Perform at Cowen
03/27/20 Cowen
Intelsat downgraded to Market Perform from Outperform at Cowen
02/10/20 Raymond James
Intelsat risk/reward more fairly valued, says Raymond James
WDFC WD-40
$175.47 /

+1.13 (+0.65%)

03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
01/07/20 DA Davidson
WD-40 downgraded to Neutral from Buy at DA Davidson
01/07/20 DA Davidson
WD-40 downgraded to Neutral from Buy at DA Davidson
AERI Aerie Pharmaceuticals
$15.24 /

+1.91 (+14.33%)

04/13/20 Mizuho
Aerie Pharmaceuticals price target lowered to $34 from $54 at Mizuho
03/23/20 SunTrust
SunTrust lowers price targets among Pharmaceuticals due to COVID-19
02/21/20 JMP Securities
Aerie Pharmaceuticals price target lowered to $35 from $41 at JMP Securities
02/13/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $45 from $48 at Piper Sandler
BOOT Boot Barn
$15.96 /

+0.18 (+1.14%)

03/30/20 Craig-Hallum
Boot Barn price target lowered to $18 from $53 at Craig-Hallum
03/13/20 Cowen
Boot Barn price target lowered to $25 from $50 at Cowen
03/11/20 Piper Sandler
Boot Barn 25% selloff in two days looks overdone, says Piper Sandler
03/10/20 Wells Fargo
Boot Barn price target lowered to $20 from $38 at Wells Fargo
Earnings
PAVmed reports Q1 non-GAAP EPS (12c), one estimate (11c) » 16:49
04/09/20
04/09
16:49
04/09/20
16:49
PAVM

PAVmed

$1.91 /

+0.01 (+0.53%)

PAVmed had cash and cash…

PAVmed had cash and cash equivalents of $6.2M as of December 31, 2019, compared with $8.2M as of December 31, 2018. Subsequently, in late March, the company received $6.3M in new gross proceeds from the prepayment of promissory notes issued in conjunction with a previously disclosed November 2019 private placement.

ShowHide Related Items >><<
Conference/Events
PAVmed to host business news update conference call » 16:25
04/09/20
04/09
16:25
04/09/20
16:25
PAVM

PAVmed

$1.91 /

+0.01 (+0.53%)

Management holds a…

Management holds a business news update conference call on April 9 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
Conference/Events
PAVmed to host business news update conference call » 04:55
04/09/20
04/09
04:55
04/09/20
04:55
PAVM

PAVmed

$1.90 /

+0.09 (+4.97%)

Management holds a…

Management holds a business news update conference call on April 9 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
Conference/Events
PAVmed to host business news update conference call » 14:49
04/05/20
04/05
14:49
04/05/20
14:49
PAVM

PAVmed

$1.79 /

-0.09 (-4.79%)

Management holds a…

Management holds a business news update conference call on April 9 at 4:30 pm. Webcast Link

ShowHide Related Items >><<
Hot Stocks
PAVmed announces FDA 510(k) re-submission for CarpX device » 09:32
03/09/20
03/09
09:32
03/09/20
09:32
PAVM

PAVmed

$2.47 /

+0.01 (+0.41%)

PAVmed Inc. announced the…

PAVmed Inc. announced the U.S. Food and Drug Administration has acknowledged receipt of a 510(k) premarket notification submission for the company's CarpX minimally invasive carpal tunnel device. "This re-submission incorporates data from the company's successful first-in-human CarpX clinical safety study, in which all patients met the study's pre-specified safety and effectiveness endpoints," the company said. PAVmed is seeking FDA 510(k) clearance to market CarpX for minimally invasive carpal tunnel release.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.